Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12113905 | 0.81 | TSHR (0.46) | FFAR1SNCAPDE3BPDE3ALOXL2 | |
| SCHEMBL1003188 | 0.81 | TSHR (0.50) | FFAR1FFAR4TSHRCYP2A6AR | |
| SCHEMBL23486299 | 0.79 | IDH1 (0.47) | FFAR1FFAR4LOXL2TSHRIDH1 | |
| SCHEMBL12427394 | 0.78 | LOXL2 (0.46) | FFAR1SNCAPDE3BPDE3ALOXL2 | |
| SCHEMBL5252001 | 0.77 | MAOB (0.43) | SNCAPDE3BPDE3ATSHR | |
| SCHEMBL10824278 | 0.72 | CYP2A6 (0.48) | FFAR1FFAR4LOXL2CYP2A6ALDH1A1 | |
| SCHEMBL14612880 | 0.72 | CYP2A6 (0.48) | FFAR1TSHRCYP2A6ALDH1A1 | |
| Bicarbonate SCHEMBL11600449 | 0.72 | LMNA (0.43) | FFAR1SNCA | |
| SCHEMBL25591817 | 0.72 | SNCA (0.40) | SNCAPDE3BPDE3ALOXL2CYP2A6 | |
| Oxalic Acid SCHEMBL11711337 | 0.71 | LMNA (0.43) | FFAR1SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11322694-B2 | Electroluminescent material, method for manufacturing same, and light emitting device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2022-05-03 | — | — | US | disclosed |
| US-20210336152-A1 | ELECTROLUMINESCENT MATERIAL, METHOD FOR MANUFACTURING SAME, AND LIGHT EMITTING DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11322694-B2 | Electroluminescent material, method for manufacturing same, and light emitting device | GPR17, CALCR, TAAR1 | FFAR1 469/4885SNCA 3491/4885FFAR4 666/4885 |
| US-20210336152-A1 | ELECTROLUMINESCENT MATERIAL, METHOD FOR MANUFACTURING SAME, AND LIGHT EMITTING DEVICE | GPR17, CALCR, TAAR1 | FFAR1 469/4885SNCA 3491/4885FFAR4 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.